James Basta - 01 Mar 2025 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Signature
James Basta
Issuer symbol
NTLA
Transactions as of
01 Mar 2025
Net transactions value
-$23,122
Form type
4
Filing time
04 Mar 2025, 16:21:45 UTC
Previous filing
07 Jan 2025
Next filing
07 Jan 2026

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Award $0 +40,000 +54% $0.000000 114,497 01 Mar 2025 Direct F1
transaction NTLA Common Stock Sale $23,122 -2,572 -2.2% $8.99 111,925 04 Mar 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTLA Stock Option (right to buy) Award $0 +57,143 $0.000000 57,143 01 Mar 2025 Common Stock 57,143 $10.09 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit
F2 Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2025, and does not represent a volitional trade by the Reporting Person.
F3 This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.